Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.

Management is scheduled to participate on Wednesday, June 12, 2024, at 1:45 pm ET and will hold one-on-one meetings. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529738025/en/

Senseonics Investor Contact
Philip Taylor
Gilmartin Group
415-937-5406
[email protected]

Source: Senseonics Holdings, Inc.

You May Also Be Interested In

• Morse Micro Announces Two Wi-Fi HaLow USB Dongle Reference Designs to Enable Long-Range Edge AI Connectivity
• TSVC Corrects Public Record: Amino Capital Founder Larry Li Was Not Involved In TSVC's 2011 Zoom Seed Investment
• Pathlock Recognized as an Overall Leader in the 2026 KuppingerCole Analysts Leadership Compass for Identity and Access Governance